<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01350622</url>
  </required_header>
  <id_info>
    <org_study_id>49065</org_study_id>
    <nct_id>NCT01350622</nct_id>
  </id_info>
  <brief_title>Efficacy of PENNSAID速 for Pain Management in the Emergency Department</brief_title>
  <official_title>Efficacy of PENNSAID速 for Pain Management in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare the pain relieving effect and speed of
      onset of PENNSAID to that of standard oral diclofenac under double blind conditions using a
      growth curve approach to pain measurement. The investigators will test the hypothesis that
      PENNSAID will provide more rapid pain relief than oral diclofenac during the ED visit. The
      secondary goal of the proposed work is to discover and model the onset and course of pain
      relief during the emergency department (ED) visit.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study never initiated
  </why_stopped>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain score</measure>
    <time_frame>Measure at 5 minute intervals for the duration of the ER visit</time_frame>
    <description>Compare the pain relieving effect and speed of onset of PENNSAID to that of standard oral diclofenac.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain trajectory model</measure>
    <time_frame>nine months</time_frame>
    <description>The secondary goal of the proposed work is to discover and model the onset and course of pain relief during the ED visit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Pain</condition>
  <condition>Ankle Sprain</condition>
  <arm_group>
    <arm_group_label>Pennsaid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active Pennsaid and oral placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Diclofenac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral diclofenac and placebo lotion (2.3% DMSO solution)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PENNSAID</intervention_name>
    <description>active treatment with PENNSAID and oral placebo. Subjects will apply 40 drops of Pennsaid to the affected ankle joint once, and will take a single placebo pill.</description>
    <arm_group_label>Pennsaid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac hydroxyethylpyrrolidine</intervention_name>
    <description>active treatment oral Diclofenac and PENNSAID placebo. Patients will take a single 50mg dose of oral diclofenac and will apply 40 drops of placebo lotion (2.3% DMSO) to the affected ankle once.</description>
    <arm_group_label>Oral Diclofenac</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:

        -We will include ED patients presenting with an acutely painful ankle sprain for which
        NSAIDs constitute standard of care pain management.

        The following will be excluded:

          -  Those with lacerations, bites, burns

          -  any head trauma

          -  pregnant

          -  anyone with a pre-existing chronic pain condition

          -  inflammatory intestinal disorders such as Crohn's disease or ulcerative colitis

          -  anyone regularly using another NSAID or anti-coagulation medication

          -  anyone who has experienced asthma after NSAID use

          -  compromised cognitive abilities

          -  a significant co-morbidity that will compromise participation

          -  had joint replacements

          -  known hypersensitivity to diclofenac or allergic responses to NSAIDs as a class

          -  active stomach and/or duodenal ulceration or gastrointestinal bleeding

          -  anyone admitted with severe active bleeding

          -  recent heart surgery

          -  severe liver or renal insufficiency

          -  prisoner

          -  mentally disabled patients

          -  wards of the state

          -  cognitive or decisional impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Chapman, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Virgil Davis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Baer PA, Thomas LM, Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord. 2005 Aug 8;6:44.</citation>
    <PMID>16086839</PMID>
  </reference>
  <reference>
    <citation>Chapman CR, Donaldson GW, Davis JJ, Bradshaw DH. Improving individual measurement of postoperative pain: the pain trajectory. J Pain. 2011 Feb;12(2):257-62. doi: 10.1016/j.jpain.2010.08.005. Epub 2011 Jan 15.</citation>
    <PMID>21237721</PMID>
  </reference>
  <reference>
    <citation>Moen MD. Topical diclofenac solution. Drugs. 2009;69(18):2621-32. doi: 10.2165/11202850-000000000-00000.</citation>
    <PMID>19943711</PMID>
  </reference>
  <reference>
    <citation>Pritchard PH, Brindley DN. Studies on the ethanol-induced changes in glycerolipid synthesis in rats and their partial reversal by N-(2-benzoyloxyethyl)norfenfluramine (benfluorex). J Pharm Pharmacol. 1977 Jun;29(6):343-9.</citation>
    <PMID>18570</PMID>
  </reference>
  <reference>
    <citation>Galer BS. A comparative subjective assessment study of PENNSAID速 and Voltaren Gel速, two topical formulations of diclofenac sodium. Pain Pract. 2011 May-Jun;11(3):252-60. doi: 10.1111/j.1533-2500.2010.00420.x. Epub 2010 Sep 20.</citation>
    <PMID>20854305</PMID>
  </reference>
  <reference>
    <citation>Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med. 2004 Oct 11;164(18):2017-23.</citation>
    <PMID>15477437</PMID>
  </reference>
  <reference>
    <citation>Rupp T, Delaney KA. Inadequate analgesia in emergency medicine. Ann Emerg Med. 2004 Apr;43(4):494-503. Review.</citation>
    <PMID>15039693</PMID>
  </reference>
  <reference>
    <citation>Todd KH, Ducharme J, Choiniere M, Crandall CS, Fosnocht DE, Homel P, Tanabe P; PEMI Study Group. Pain in the emergency department: results of the pain and emergency medicine initiative (PEMI) multicenter study. J Pain. 2007 Jun;8(6):460-6. Epub 2007 Feb 15.</citation>
    <PMID>17306626</PMID>
  </reference>
  <reference>
    <citation>Towheed TE. Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials. J Rheumatol. 2006 Mar;33(3):567-73. Review.</citation>
    <PMID>16511925</PMID>
  </reference>
  <reference>
    <citation>Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004 Oct;31(10):2002-12.</citation>
    <PMID>15468367</PMID>
  </reference>
  <reference>
    <citation>Hui X, Hewitt PG, Poblete N, Maibach HI, Shainhouse JZ, Wester RC. In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers. Pharm Res. 1998 Oct;15(10):1589-95.</citation>
    <PMID>9794502</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2011</study_first_submitted>
  <study_first_submitted_qc>May 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2011</study_first_posted>
  <last_update_submitted>December 19, 2016</last_update_submitted>
  <last_update_submitted_qc>December 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Ankle Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Diclofenac hydroxyethylpyrrolidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

